Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
Scientific Reports
|
September 26, 2020
Assessing the need for pioglitazone in the treatment of patients with type 2 diabetes: a meta-analysis of its risks and benefits from prospective trials
Binayak Sinha, Samit Ghosal
Diabetes Research and Clinical Practice
|
February 23, 2019
Meta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failure
Binayak Sinha, Samit Ghosal
Diabetes & Metabolic Syndrome
|
January 3, 2017
Secondary cvd prevention-Lipid modification strategies: A critical analysis
Samit Ghosal, Binayak Sinha
Journal of Diabetes Research
|
December 10, 2015
Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOS
Samit Ghosal, Binayak Sinha
Diabetes & Metabolic Syndrome
|
March 26, 2014
India suspends pioglitazone: is it justified?
S M Sadikot, Samit Ghosal
The Journal of the Association of Physicians of India
|
August 24, 2017
Consensus on Bridges for Barriers to Insulin Therapy
Sanjay Kalra, Samit Ghosal, Parag Shah
Scientific Reports
|
November 12, 2021
A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D)
Samit Ghosal, Debasis Datta, Binayak Sinha
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
February 8, 2021
Meta-analysis of the effects of sodium glucose cotransporter 2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes
Binayak Sinha, Debasis Datta, Samit Ghosal
World Journal of Diabetes
|
November 1, 2016
Glucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndrome
Sanjay Chatterjee, Samit Ghosal, Saurav Chatterjee
Journal of Clinical Medicine
|
October 28, 2023
The Renal Composite Benefit of Sodium Glucose Co-Transporter 2 Inhibitors Should Ideally Be Assessed Based on a Standardised Definition: A Meta-Analysis of Randomised Controlled Trials
Samit Ghosal, Shamita Ghosal, Anuradha Ghosal
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
Scientific Reports
|
September 26, 2020
Assessing the need for pioglitazone in the treatment of patients with type 2 diabetes: a meta-analysis of its risks and benefits from prospective trials
Binayak Sinha, Samit Ghosal
Diabetes Research and Clinical Practice
|
February 23, 2019
Meta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failure
Binayak Sinha, Samit Ghosal
Diabetes & Metabolic Syndrome
|
January 3, 2017
Secondary cvd prevention-Lipid modification strategies: A critical analysis
Samit Ghosal, Binayak Sinha
Journal of Diabetes Research
|
December 10, 2015
Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOS
Samit Ghosal, Binayak Sinha
Diabetes & Metabolic Syndrome
|
March 26, 2014
India suspends pioglitazone: is it justified?
S M Sadikot, Samit Ghosal
The Journal of the Association of Physicians of India
|
August 24, 2017
Consensus on Bridges for Barriers to Insulin Therapy
Sanjay Kalra, Samit Ghosal, Parag Shah
Scientific Reports
|
November 12, 2021
A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D)
Samit Ghosal, Debasis Datta, Binayak Sinha
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
February 8, 2021
Meta-analysis of the effects of sodium glucose cotransporter 2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes
Binayak Sinha, Debasis Datta, Samit Ghosal
World Journal of Diabetes
|
November 1, 2016
Glucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndrome
Sanjay Chatterjee, Samit Ghosal, Saurav Chatterjee
Journal of Clinical Medicine
|
October 28, 2023
The Renal Composite Benefit of Sodium Glucose Co-Transporter 2 Inhibitors Should Ideally Be Assessed Based on a Standardised Definition: A Meta-Analysis of Randomised Controlled Trials
Samit Ghosal, Shamita Ghosal, Anuradha Ghosal
Page
of 6